8NE:FRA
Lisata Therapeutics, Inc.
€ 0.82
arrow_downward
-0.61%(-0.0050) Siku 1
13 Okt, 11:46:17 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 8NE...
Fungua
€ 0.82
Juu
€ 0.82
Chini
€ 0.82
Mtaji wa soko
11.29M
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 4.34
Chini kwa wiki 52
€ 0.74
Idadi ya wafanyakazi
21
Fungua
€ 0.82
Juu
€ 0.82
Chini
€ 0.82
Mtaji wa soko
11.29M
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 4.34
Chini kwa wiki 52
€ 0.74
Idadi ya wafanyakazi
21
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
巴士的報
·
dakika 12 zilizopita
NYSE Touches Down at TechCrunch Disrupt: NYSE Content Update
The Seattle Times
·
dakika 12 zilizopita
The first big batch of US profit reports for the summer has Wall Street mixed
kalkine.ca
·
dakika 17 zilizopita
What Hit Syndax (NASDAQ:SNDX), Summit (NASDAQ:SMMT), Scribe (NASDAQ:SCTX) and Surrozen (NASDAQ:SRZN) on October 13?
Yahoo Finance
·
saa 1 iliyopita
XRP Fell 8% in the Week It Got a Nasdaq Listing, a Dubai Bank Deal and an ETF Inflow. Why Did None of It Count?
Wasifu
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Kuhusu Lisata Therapeutics, Inc.
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi21
Lilianzishwa1980
Makao makuuBasking Ridge, New Jersey, Marekani
Sekta-
Tovutilisata.com